BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 21575525)

  • 21. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma.
    Ji YB; Lee KJ; Park YS; Hong SM; Paik SS; Tae K
    Ann Surg Oncol; 2012 Jun; 19(6):1868-73. PubMed ID: 21989668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
    Degnim AC; Oh K; Cimmino VM; Diehl KM; Chang AE; Newman LA; Sabel MS
    Ann Surg Oncol; 2005 Sep; 12(9):712-7. PubMed ID: 16079955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of sentinel lymph node in patients with early stage breast cancer].
    Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM
    Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
    Gentilini O; Veronesi P; Botteri E; Soggiu F; Trifirò G; Lissidini G; Galimberti V; Musmeci S; Raviele PR; Toesca A; Ratini S; Del Castillo A; Colleoni M; Talakhadze N; Rotmensz N; Viale G; Veronesi U; Luini A
    Ann Surg Oncol; 2011 Oct; 18(10):2879-84. PubMed ID: 21479691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy indications and controversies in breast cancer.
    Wiatrek R; Kruper L
    Maturitas; 2011 May; 69(1):7-10. PubMed ID: 21411254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
    Takei H; Kurosumi M; Yoshida T; Ishikawa Y; Hayashi Y; Ninomiya J; Tozuka K; Oba H; Inoue K; Nagai S; Saito Y; Kazumoto T; Saitoh J; Tabei T
    Breast Cancer; 2010; 17(1):9-16. PubMed ID: 19701679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
    Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
    J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
    Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
    Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer.
    Wu X; Lin Q; Chen G; Lu J; Zeng Y; Chen X; Yan J
    PLoS One; 2015; 10(8):e0135714. PubMed ID: 26296136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
    Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
    J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.
    Noguchi M; Inokuchi M; Zen Y
    J Surg Oncol; 2009 Aug; 100(2):100-5. PubMed ID: 19479943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.
    Lovrics PJ; Chen V; Coates G; Cornacchi SD; Goldsmith CH; Law C; Levine MN; Sanders K; Tandan VR
    Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer.
    Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W
    J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.